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Abstract
Introduction The steroid hormone dehydroepiandrosterone
(DHEA) exerts protecting effects in the treatment of traumatic
and septic complications in several animal models. This effect
goes along with reduced amounts of infiltrating immune cells in
organs such as lung and liver. However, the underlying
mechanisms of DHEA action are still not known. Adhesion
molecules are important for the extravasation of neutrophils into
organs where they may exhibit detrimental effects. Therefore, we
investigated the in vitro effect of DHEA on the expression
pattern of adhesion molecules of human endothelial cells and
neutrophils.
Methods Endothelial cells derived from human umbilical cord
were subjected to an lipopolysaccharide (LPS) challenge.
DHEA was administered in two different concentrations, 10-5 M
and 10-8 M, as a single stimulus or in combination with LPS
challenge. After two, four and 24 hours, fluorescence activated
cell sorter (FACS) analysis for vascular cell adhesion molecule-
1, intercellular adhesion molecule-1 and E-selectin was
performed. Neutrophils were freshly isolated from blood of 10
male healthy volunteers, stimulated the same way as endothelial
cells and analyzed for surface expression of L-selectin, CD11b
and CD18.
Results In the present study, we were able to demonstrate
effects of DHEA on the expression of every adhesion molecule
investigated. DHEA exhibits opposite effects to those seen
upon LPS exposure. Furthermore, these effects are both time
and concentration dependent as most DHEA specific effects
could be detected in the physiological concentration of 10-8 M.
Conclusion Thus, we conclude that one mechanism by which
DHEA may exert its protection in animal models is via the
differential regulation of adhesion molecule expression.
Introduction
Trauma and sepsis are the leading causes of death in devel-
oped countries; incidence of mortality in septic patients could
reach as high as 30% [1,2]. The reasons for this high inci-
dence are very complex. After multiple trauma and/or sepsis
the immune system becomes highly activated. Once the
inflammatory cascade is initiated, it often results in a systemic
inflammatory reaction that involves a variety of body systems,
for example, the complement system [3,4], the coagulation
system [5,6] and the bradykinin-kinin system [7,8]. After a few
days, this physiological process will be resolved in some
patients and they will convalesce, while in others it could lead
to death. Despite years of research, the exact mechanisms
underlying these different responses are still unknown.
The extravasation of leukocytes from the vascular bed into sur-
rounding tissues and organs is part of the host defense mech-
anisms against invading pathogens. However, it could be one
of the key factors contributing to organ failure and death in
cases of disturbed body homeostasis. Activated by cytokines
and chemokines, leukocytes and endothelial cells express dis-
tinct adhesion molecules on their cell surfaces [9]. These
adhesion molecules enable the deceleration of blood cells on
the endothelial layer in order to enable subsequent diapedesis.
In the first phase of the extravasation process, selectins such
as L-selectin on leukocytes and E- and P-selectin on endothe-
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lial cells lead to a loose connection that permits tethering and
rolling of leukocytes on the endothelium under hydrodynamic
shear [10]. Stable attachments between leukocytes and
endothelial cells take place through interactions of integrins
like CD18/CD11b, expressed on leukocytes [11], with their
immunoglobulin-like ligands, such as intercellular adhesion
molecule (ICAM)-1 and vascular cell adhesion molecule
(VCAM)-1, which are expressed on endothelium [11,12]. The
importance of adhesion molecules in traumatic and septic dis-
eases has been widely recognized. A recent study by our
group performed in ICAM-1 knockout mice demonstrated a
significant reduction in mortality after trauma and sepsis
[13,14]. Similar beneficial results can be obtained from stud-
ies inhibiting other adhesion molecules, such as L-selectin
[15,16], P-selectin [17,18], E-selectin [19], CD11b [20,21]
and CD18 [22]. Maekawa and colleagues [23] demonstrated
that increases in expression levels of L-selectin, sL-selectin
and CD11b correlate with injury severity after trauma. Thus,
adhesion molecules seem to have an influence on the out-
come and severity of complications after trauma and sepsis
and are, therefore, interesting candidates for medication and
drug targets.
Previous studies by our group dealing with the therapeutic
effect of the steroid hormone dehydroepiandrosterone
(DHEA) revealed that it is protective in a murine model of com-
bined trauma and sepsis [24-27]. DHEA is the most abundant
steroid hormone of the body and is a precursor of sexual hor-
mones, such as 7-β-estradiol and 5-α-dihydrotestosterone.
Additionally, we demonstrated that DHEA administration
resulted in a reduced amount of granulocyte infiltration into
organs [28].
Because of our previous findings concerning neutrophil
extravasation in DHEA treated mice, we postulate that DHEA
has either a direct or an indirect effect on the expression of
adhesion molecules on leukocytes or endothelial cells. To
investigate this phenomenon, we performed cell culture exper-
iments with granulocytes and endothelial cells and determined
expression levels of adhesion molecules during DHEA treat-
ment after endotoxin (lipopolysaccharide (LPS)) challenge.
LPS was chosen to mimic a 'septic' state in the cell environ-
ment. Experiments using DHEA treatment after LPS challenge
should reveal if DHEA is able to attenuate inflammatory LPS
effects.
Materials and methods
Endothelial cell culture and stimulation
The study was approved by the ethical committee of Hannover
Medical School.
Endothelial cells were isolated and cultured from human umbil-
ical cord vein, and are designated as human umbilical vein
endothelial cells (HUVECs; n = 7). Fresh umbilical cords of 10
to 30 cm were prepared by inserting cannulas in both ends of
the umbilical cord vein. Via the cannula, the vein was rinsed
with sterile, prewarmed cord buffer (3.0 mM NaH2PO4·H2O;
9.0 mM Na2HPO4·2H2O; 140 mM NaCl; 8.5 mM
MgCl2·6H2O; 11 mM glucose), filled with collagenase (0.04%
w/v in cord buffer; Gibco, Grand Island, USA) solution and
sealed at both ends. Enzyme incubation was conducted for 30
minutes at 37°C to release endothelial cells from the extracel-
lular matrix. After incubation, collagenase solution containing
endothelial cells was eluted from the umbilical cord, cells were
washed by centrifugation in PBS and plated in T25 cell culture
bottles (Cell+, Greiner, Frickenhausen, Germany) in Endothe-
lial Cell Culture Medium (Promocell, Heidelberg, Germany).
Cells were grown to sub-confluence and passaged by enzy-
matic detachment with Trypsin/EDTA (Biochrom, Berlin, Ger-
many). After another washing step, 2.5 × 105 cells were
seeded and expanded in passage 1 into T75 cell culture bot-
tles. Cells from passages 1 to 3 were used for the experi-
ments.
For the experimental procedure, 5 × 104 cells were seeded
into 6-well plates and grown to sub-confluence. In the sub-
confluential state, cells were exposed to 100 ng/ml LPS
obtained from Escherichia coli O111:B7 (Sigma, Deisen-
hofen, Germany). Additionally, cells were treated upon LPS
incubation with two different DHEA concentrations (10-5 M or
10-8 M; Sigma, Deisenhofen, Germany); these concentrations
were also used as single stimuli to determine DHEA specific
effects. Unstimulated cells were used as internal controls
(Table 1). Experiments were performed for two, four, and 24
hours.
Table 1
Overview of the experimental setting: measurement times, treatment procedures and concentrations
Time Treatment
2 h Control LPS 100 ng/ml DHEA 10-5 MD H E A  1 0 -8 M LPS (100 ng/ml) + 
10-5 M DHEA
LPS (100 ng/ml) + 
10-8 M DHEA
4 h Control LPS 100 ng/ml DHEA 10-5 MD H E A  1 0 -8 M LPS (100 ng/ml) + 
10-5 M DHEA
LPS (100 ng/ml) + 
10-8 M DHEA
24 h Control LPS 100 ng/ml DHEA 10-5 MD H E A  1 0 -8 M LPS (100 ng/ml) + 
10-5 M DHEA
LPS (100 ng/ml) + 
10-8 M DHEAAvailable online http://ccforum.com/content/10/4/R109
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Polymorph nuclear neutrophil isolation and stimulation
EDTA-blood was drawn from healthy male volunteers (n = 10)
with an average age of 28 ± 5 years. Volunteers with any kind
of disease, especially persons suffering from systemic inflam-
matory disorders, were excluded from the study. Blood was
diluted 1:2 and a first separation step was performed by Ficoll
gradient centrifugation. Neutrophils in the pellet of the gradient
were separated from erythrocytes by further steps consisting
of dextran sedimentation and hypotonic lysis. Cells (106/ml)
were seeded into 24-well plates (Greiner) using RPMI 1640
medium (Biochrom) containing 10% serum of the respective
volunteer. Stimulation was performed immediately after isola-
tion as described for endothelial cells with stimulation times of
two, four and 24 hours. Again, untreated cells were used as
internal controls.
Flow cytometry
For flow cytometry analysis, antibodies against VCAM-1,
ICAM-1, E-selectin, L-selectin, CD11b and CD18 were used.
Human endothelial cells were investigated for the expression
of VCAM-1, ICAM-1 and E-selectin. Human polymorph
nuclear neutrophils were stained with anti-L-selectin, anti-
CD11b and anti-CD18. All antibodies used for flow cytometric
analysis were obtained from Becton Dickinson (San Jose, CA,
USA), except the CD62L specific antibody, which was pur-
chased from BenderMedSystems (Vienna, Austria). Stimula-
tion was stopped by adding 1 ml of ice-cold PBS to the cell
suspension. Endothelial cells were detached using a cell
scraper (Greiner). Cells were transferred into round bottom
polypropylene tubes (Becton Dickinson). After pelleting by
centrifugation, cells were washed again and resuspended in
100 µl PBS containing 10 µl of the respective antibody solu-
tion. Cells were incubated for 30 minutes at 4°C. Subse-
quently, cells were washed with PBS and resuspended in 300
µl PBS for flow cytometric analysis. Analysis was conducted
on a FACSCalibur (Becton Dickinson) with individual settings
for each antibody utilizing Cell Quest Pro Software (Becton
Dickinson). Unstained cells were used to discriminate autoflu-
orescence and to adjust forward and side scatter. Amounts of
positive cells were given in percent. For further analysis, rela-
tive expression was calculated by the ratio of stimulated cells
Table 2
Values of relative vascular cell adhesion molecule-1 expression
Time LPS 10-5 M DHEA 10-8 M DHEA LPS/10-5 M DHEA LPS/10-8 M DHEA
2 h 100.13 ± 12.31 81.73 ± 6.44 74.02 ± 14.55 64.43 ± 8.14 62.35 ± 7.81
4 h 110.32 ± 17.1 95.12 ± 27.51 91.93 ± 26.85 153.16 ± 57.9 132.82 ± 42.03
24 h 99.58 ± 19.32 79.56 ± 11.98 66.16 ± 18.23 77.73 ± 8.58 70.05 ± 14.88
Levels are calculated against unstimulated controls (= 100%) and are given in percent ± standard error of the mean. Highlighted values at 2 h are 
significant compared to unstimulated and lipopolysaccharide (LPS); highlighted values at 24 h are significant compared to unstimulated. DHEA, 
dehydroepiandrosterone.
Figure 1
Relative vascular cell adhesion molecule-1 expression levels Relative vascular cell adhesion molecule-1 expression levels: ##10-5 M dehydroepiandrosterone (DHEA) significant compared to unstimulated and 
lipopolysaccharide (LPS); ###10-8 M DHEA significant compared to unstimulated and LPS; ####LPS/10-5 M DHEA significant compared to unstimu-
lated and LPS; #####LPS/10-8 M DHEA significant compared to unstimulated and LPS; ****LPS/10-5 M DHEA significant compared to unstimulated; 
*****LPS/10-8 M DHEA significant compared to unstimulated.Critical Care    Vol 10 No 4    Barkhausen et al.
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to unstimulated cells and presented in percent (100% =
expression level of unstimulated cells).
Statistics
Statistical analysis was performed using a standard software
application (SPSS, SPSS Inc., Chicago, IL, USA). Compari-
sons between groups were performed using one-way analysis
of variances (ANOVA) followed by Student t test. Probability
values less then 0.05 were considered statistically significant.
The data are expressed as mean ± standard error of the mean.
Results
Adhesion molecule expression of HUVECs in vitro
VCAM-1 expression
LPS had no modulating effects on VCAM-1 expression in this
experimental setting (Table 2, Figure 1).
In contrast, DHEA of both concentrations, in single stimulation
experiments as well as in experiments using DHEA treatment
after LPS challenge, induced a down-regulation of membrane-
bound VCAM-1 after two hours (Table 2, Figure 1) compared
to controls and LPS treated samples. Expression levels tended
to normalize in single DHEA treated samples until the final
observation time (Table 2, Figure 1). This down-regulation was
also detectable after 24 hour treatment with DHEA after LPS
challenge (Table 2, Figure 1).
Interestingly, all groups showed expression peaks in the time
course after four hours, with no significant differences
between the groups (Table 2, Figure 1).
ICAM-1 expression
LPS induced a steady increase of ICAM-1 expression over the
time course in all groups, with peak ICAM-1 expression levels
after 24 hours. Significant differences compared to controls
were measurable two hours after treatment with LPS/10-8 M
DHEA, and for all LPS stimulated groups after 24 hours (Table
3, Figure 2). A significant up-regulation of ICAM-1 occurred
with 10-8 M DHEA alone after two and 24 hours but, in con-
trast to LPS, alterations caused by 10-8 M DHEA were not so
pronounced. ICAM-1 expression was not affected by 10-5 M
DHEA, either alone or after LPS challenge (Table 3, Figure 2).
Table 3
Values of relative intercellular adhesion molecule-1 expression
Time LPS 10-5 M DHEA 10-8 M DHEA LPS/10-5 M DHEA LPS/10-8 M DHEA
2 h 123.53 ± 10.56 104.97 ± 3.84 116.11 ± 4.33 102.87 ± 5.88 130.76 ± 8.41
4 h 169.02 ± 41.34 84.33 ± 9.84 115.58 ± 14.38 143.49 ± 33.42 147.88 ± 29.86
24 h 434.9 ± 108.6 104.08 ± 9.08 123.02 ± 10.2 413.36 ± 106.17 414.96 ± 105.43
Levels are calculated against unstimulated controls (= 100%) and are given in percent ± standard error of the mean. Highlighted values are 
significant compared to unstimulated. DHEA, dehydroepiandrosterone; LPS = lipopolysaccharide.
Figure 2
Relative intercellular adhesion molecule-1 expression levels Relative intercellular adhesion molecule-1 expression levels: *lipopolysaccharide (LPS) significant compared to unstimulated; ***10-8 M dehydroepi-
androsterone (DHEA) significant compared to unstimulated; ****LPS/10-5 M DHEA significant compared to unstimulated; *****LPS/10-8 M DHEA 
significant compared to unstimulated.Available online http://ccforum.com/content/10/4/R109
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E-selectin expression
After two hours of stimulation, incubation with 10-8 M DHEA
resulted in a reduction of E-selectin expression. This effect
was detected after single stimulation as well as after stimula-
tion with LPS and DHEA (Table 4, Figure 3).
E-selectin expression levels peaked at four hours in all groups,
with significantly up-regulated values compared to unstimu-
lated controls in all LPS treated groups (Table 4, Figure 3).
These levels seemed to normalize after 24 hours. Single treat-
ment with 10-8  M DHEA caused a significantly reduced
expression of E-selectin (Table 4, Figure 3).
Adhesion molecule expression of human neutrophils in 
vitro
L-selectin expression
During exposure to LPS, L-selectin is rapidly shed from cell
surfaces. After two hours, its expression levels in LPS treated
groups were significantly reduced, with levels tending to zero
(Table 5, Figure 4). Levels started to recover in the LPS
treated groups after four and 24 hours, but were still signifi-
cantly decreased (Table 5, Figure 4).
In contrast, stimulation with 10-8 M DHEA caused an up-regu-
lation of L-selectin expression after two hours (p < 0.05). Lev-
els showed no significant changes with 10-5 M DHEA and with
10-8 M DHEA at the later measurement points (Table 5, Figure
4).
CD11b expression
At two and four hours after stimulation, CD11b expression
was not affected by either LPS or DHEA at any concentration
(Table 6, Figure 5).
Expression of CD11b was significantly up-regulated in all sam-
ples stimulated with LPS (with and without DHEA treatment)
compared to unstimulated controls at 24 hours (Table 6, Fig-
ure 5). In contrast, single treatment with 10-8 M DHEA resulted
in a significant decrease in CD11b expression (Table 6, Figure
5).
CD18 expression
At two hours, all LPS stimulated groups showed significant
increases in CD18 expression levels (Table 7, Figure 6). This
effect was also observed after four hours. After 24 hours,
Table 4
Values of relative E-selectin expression
LPS 10-5 M DHEA 10-8 M DHEA LPS/10-5 M DHEA LPS/10-8 M DHEA
2 h 105.03 ± 13.63 84.03 ± 8.46 84.64 ± 8.5 81.75 ± 9.79 83.62 ± 3.8
4 h 220.11 ± 53.07 123.47 ± 17.39 120.87 ± 30.71 217.23 ± 52.27 210.59 ± 40.36
24 h 137.05 ± 33.49 90.15 ± 6.42 71.9 ± 9.02 98.13 ± 10.87 123.07 ± 23.38
Levels are calculated against unstimulated controls (= 100%) and are given in percent ± standard error of the mean. Highlighted values are 
significant compared to unstimulated. DHEA, dehydroepiandrosterone; LPS = lipopolysaccharide.
Figure 3
Relative E-selectin expression levels Relative E-selectin expression levels: *lipopolysaccharide (LPS) significant compared to unstimulated; ***10-8 M dehydroepiandrosterone (DHEA) 
significant compared to unstimulated; ****LPS/10-5 M DHEA significant compared to unstimulated; *****LPS/10-8 M DHEA significant compared to 
unstimulated.Critical Care    Vol 10 No 4    Barkhausen et al.
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CD18 expression tended to recover in the LPS treated groups
but was still significantly increased compared to unstimulated
controls (Table 7, Figure 6).
In contrast to LPS, a single treatment with 10-8 M DHEA
resulted in an early decrease of CD18 expression after two
hours, but after 24 hours DHEA had not affected CD18
expression compared to unstimulated controls (Table 7, Fig-
ure 6).
Discussion
The steroid hormone DHEA has been shown to be beneficial
in animal experiments of trauma or sepsis [24-27]. Previous
studies by our group revealed that these beneficial effects are
concomitant with a reduced amount of infiltrating neutrophils
in distinct tissue sites, for example, lung tissue [28]. As neu-
trophil extravasation is mainly caused by adhesion molecules,
we suggested that DHEA has a specific effect on adhesion
molecule expression. In the present study we demonstrate that
DHEA has distinct in vitro effects on surface expression pat-
terns of adhesion molecules of endothelial and neutrophil ori-
gin. Interestingly, we observed that the mode of DHEA action
is different with different adhesion molecules. Additionally, we
detected time-dependent effects as well as DHEA concentra-
tion-dependent effects.
In the present study, we used two different concentrations of
DHEA (10-5 M and 10-8 M). As a first important finding, the
strongest effects of DHEA occurred with a DHEA concentra-
tion of 10-8 M compared to a concentration of 10-5 M. A direct
effect of 10-5 M DHEA could only be detected on VCAM-1
expression. All other DHEA-dependent changes were
observed after treatment with 10-8 M DHEA. This result is inter-
esting because a concentration of 10-8 M resembles the phys-
iological DHEA concentration. Normal DHEA serum levels
show values of 10 nmol/l [29]. Thus, at least in the current
experimental setting, super-physiological concentrations of
DHEA are less efficacious than the physiological range.
Adhesion molecules are influenced under septic conditions.
LPS, a component found in the outer membrane of Gram-neg-
ative bacteria, is one of the key players mediating septic
Table 5
Values of relative L-selectin expression
LPS 10-5 M DHEA 10-8 M DHEA LPS/10-5 M DHEA LPS/10-8 M DHEA
2 h 4.66 ± 1.47 98.36 ± 11.3 121.83 ± 8.6 4.81 ± 1.21 5.01 ± 1.63
4 h 49.25 ± 13.22 111.88 ± 15.78 156.24 ± 62.53 45.02 ± 12.12 47.25 ± 17.27
24 h 59.77 ± 7.33 94.28 ± 2.87 97.4 ± 3.86 48.08 ± 6.02 53.26 ± 7.38
Levels are calculated against unstimulated controls (= 100%) and are given in percent ± standard error of the mean. Highlighted values are 
significant compared to unstimulated. DHEA, dehydroepiandrosterone; LPS = lipopolysaccharide.
Figure 4
Relative L-selectin expression levels Relative L-selectin expression levels: *lipopolysaccharide (LPS) significant compared to unstimulated; ***10-8 M dehydroepiandrosterone (DHEA) 
significant compared to unstimulated; ****LPS/10-5 M DHEA significant compared to unstimulated; *****LPS/10-8 M DHEA significant compared to 
unstimulated.Available online http://ccforum.com/content/10/4/R109
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effects. With LPS as the single inflammatory stimuli in vitro,
adhesion molecules exhibit divergent time courses of expres-
sion. In this experimental setting investigating human neu-
trophils and endothelial cells, the time courses of expression
were likewise dependent on the adhesion molecule studied.
We observed constant increases in the expression patterns of
ICAM-1 and CD11b, a peak expression after four hours of
stimulation with LPS for E-selectin, and an early induction of
CD18 followed by a down-regulation over the time course. In
contrast, L-selectin was rapidly shed from cell surfaces but its
levels recovered, although not to baseline levels, over the time
course. Similar to our results, analogous adhesion molecule
dependent time courses of expression can be observed after
stimulation with other inflammatory molecules, such as tumour
necrosis factor-α and interleukin-1β [30,31]. The physiological
background for these distinct reaction types, such as shed-
ding or up-regulation, is not yet clear and requires further
investigation.
One interesting finding was that LPS exhibited no effect on
VCAM-1 expression. This was unexpected as several results
from the literature refer to increases in VCAM-1 expression
after LPS treatment [32-34]. Explanations for this discrepancy
may be different culture conditions and different LPS concen-
trations; in the studies mentioned above, different medium
types and serum concentrations were used compared to our
experimental setting. Additionally, the LPS concentration used
in these studies were higher, ranging from 1 µg/ml to 20 µg/
ml [32-34], compared to the present study, which used 100
ng/ml. However, the main focus of this study was the potential
modulation of adhesion molecules by DHEA. Thus, we demon-
strated that treatment of endothelial cells with DHEA in each
setting results in an abrogation of VCAM-1 expression from
the cell surface at the earliest measurement point (after two
hours). Additionally, after 24 hours a reduction was still detect-
able, but only in the DHEA treated samples. Therefore, we
suggest that a DHEA-dependent reduction of VCAM-1 with an
enhancing function of LPS occurred. A similar decline in
expression after DHEA treatment was observed for E-selectin
at two and 24 hours. Additionally, DHEA administration
resulted in a decrease of ICAM-1, CD11b and CD18 at vary-
ing time points. In contrast to these reductions induced by
Table 6
Values of relative CD11b expression
LPS 10-5 M DHEA 10-8 M DHEA LPS/10-5 M DHEA LPS/10-8 M DHEA
2 h 103.53 ± 3.46 101.7 ± 2.61 101.45 ± 2.51 103.84 ± 3.38 102.61 ± 3.56
4 h 103.16 ± 2.37 100.85 ± 1.15 101.85 ± 1.58 103.96 ± 2.03 104.12 ± 1.9
24 h 112.18 ± 3.48 101.28 ± 2.19 95.05 ± 1.85 111.82 ± 3.69 115.35 ± 4.19
Levels are calculated against unstimulated controls (= 100%) and are given in percent ± standard error of the mean. Highlighted values are 
significant compared to unstimulated. DHEA, dehydroepiandrosterone; LPS = lipopolysaccharide.
Figure 5
Relative CD11b expression levels Relative CD11b expression levels: *lipopolysaccharide (LPS) significant compared to unstimulated; ***10-8 M dehydroepiandrosterone (DHEA) sig-
nificant compared to unstimulated; ****LPS/10-5 M DHEA significant compared to unstimulated; *****LPS/10-8 M DHEA significant compared to 
unstimulated.Critical Care    Vol 10 No 4    Barkhausen et al.
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DHEA, we found a DHEA-triggered increase of L-selectin
expression. This is of interest, as DHEA seems to reverse the
LPS specific response of each adhesion molecule in all cases
when comparing single stimulations. This means, in cases
where LPS alone induces up-regulation, incubation with solely
DHEA results in a decrease and vice versa. Thus, we conclude
that there is a direct correlation between the modulating effect
of DHEA and the inflammatory context.
The mode of action by which DHEA influences certain adhe-
sion molecules may occur at the signal transduction level.
DHEA is known to influence distinct signal transduction path-
ways, such as the phosphoinositide 3-kinase (PI3K)/Akt, p38
mitogen-activated protein kinase (MAPK) and glycogen syn-
thase kinase (GSK)-3β pathways [35-37]. It is possible that
DHEA acts as an inhibitor of these kinases through dephos-
phorylation via a DHEA-enhanced dual specificity protein
phosphatase [37]. As adhesion molecules are themselves
influenced by a variety of signal kinases, such as protein kinase
C-δ, phosphoinositide 3-kinase, Src, p38, JNK, extracellular
signal-regulated kinase (ERK)1/2, and glycogen synthase
kinase-3 [38-44], an interrelationship between DHEA and
adhesion molecule expression on the signal transduction level
can be considered and is under further investigation.
Experiments using DHEA treatment after LPS challenge in this
study were designed to determine whether DHEA is able to
directly modulate or rather reverse LPS specific effects. The
results show that DHEA does not have the ability to modulate
LPS induced changes in adhesion molecule expression in this
experimental setting. However, it must be taken into account
that the study was performed in an in vitro environment. Thus,
the results might be dependent on concentrations of LPS and
DHEA. Additionally, important co-factors might be missing
that are ordinarily available in an in vivo environment. Despite
this, DHEA does modulate adhesion molecules when LPS is
not present or has no influence itself, and an effect under phys-
iological conditions can thus be speculated to occur.
Table 7
Values of relative CD18 expression
LPS 10-5 M DHEA 10-8 M DHEA LPS/10-5 M DHEA LPS/10-8 M DHEA
2 h 240.86 ± 62.38 101.48 ± 14.28 84.88 ± 5.02 225.73 ± 58.03 232.53 ± 60.76
4 h 246.21 ± 73.37 94.1 ± 14.71 88.1 ± 12.69 244.21 ± 70.64 211.68 ± 77.56
24 h 107.15 ± 2.98 100.97 ± 1.31 96.83 ± 2.26 105.91 ± 2.45 105.95 ± 2.46
Levels are calculated against unstimulated controls (= 100%) and are given in percent ± standard error of the mean. Highlighted values are 
significant compared to unstimulated. DHEA, dehydroepiandrosterone; LPS = lipopolysaccharide.
Figure 6
Relative CD18 expression levels Relative CD18 expression levels: *lipopolysaccharide (LPS) significant compared to unstimulated; ***10-8 M dehydroepiandrosterone (DHEA) signif-
icant compared to unstimulated; ****LPS/10-5 M DHEA significant compared to unstimulated; *****LPS/10-8 M DHEA significant compared to 
unstimulated.Available online http://ccforum.com/content/10/4/R109
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Conclusion
We have demonstrated that DHEA exhibits modulating effects
on adhesion molecule expression of human endothelial cells
and neutrophils in an in vitro environment. Furthermore, we
found that modulating effects triggered by DHEA treatment
were always opposite to the effects induced by LPS. However,
these effects could not be detected when DHEA was applied
after LPS challenge. Thus, DHEA was not able to reverse
inflammatory effects in vitro. Nevertheless, we do conclude
that one mechanism of action by which DHEA exerts protec-
tive effects is via the modulation of adhesion molecules as
DHEA alone did affect adhesion molecule expression. In this
experimental setting, cofactors that are essential for the mod-
ulation of inflammatory responses in vivo might have been
missing.
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